LEP and hypertensive disorder: Similar to other atypical antipsychotics, olanzapine use has been connected with various metabolic effects such as weight gain, accumulation of visceral fat, hyperlipidemia, increased blood leptin levels, insulin resistance, diabetes type 2, and high blood pressure (Akinola et al., 2023; Li et al., 2019; Wu et al., 2022).